Hydromorphone Hydrochloride Injection, Solution
Product Images NDC 0703-0113

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Hydromorphone Hydrochloride (NDC 0703-0113). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Parenteral Medicines, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Hydromorphone 01)

FDA Label Image

Principal Display Panel (1 mL Vial Label)

Principal Display Panel (1 mL Vial Label)
This is a description of a medication called Hydromorphone Hydrochloride Injection. It comes in a single-dose vial and is manufactured by Teva Pharmaceuticals in North Wales, PA. The lot number and expiration date are also provided. The medication is only available with a prescription.*
FDA Label Image

Principal Display Panel (1 mL Vial Carton)

Principal Display Panel (1 mL Vial Carton)
Hydromorphone Hydrochloride Injection, USP is a medication packaged in 10 single-dose vials each containing 1 mL of solution. Each vial has 10 mg of hydromorphone hydrochloride. This medication is used to relieve moderate to severe pain. The medication should be stored at temperatures between 20-25°C. The unit packaging should not be broken until ready for use. Each vial contains enough medication for a single dose. Refer to the package insert for full prescribing information.*
FDA Label Image

Principal Display Panel (5 mL Vial Label)

Principal Display Panel (5 mL Vial Label)
This is a description of a medication called Hydromorphone Wid For Hydrochloride Injection, USP. It is a high potency formulation and is only available with a prescription. The medication comes in a 5 mL single-dose vial and has a strength of 50mg/5mL. It is intended for use in preparing large-volume parenteral solutions. The text also includes information on the manufacturer, FPOGS1 Databar Limited, and the NDC (National Drug Code) for the medication. The expiration date is also provided.*
FDA Label Image

Principal Display Panel (5 mL Vial Carton)

Principal Display Panel (5 mL Vial Carton)
Hydromorphone Hydrochloride Injection, USP is a medication available in single-dose vials containing 50mg/5mL of hydromorphone hydrochloride to be used for large-volume parenteral solutions. Each vial contains a sufficient volume of medication to permit withdrawal of 0.5mL. The medication is stored at 20-25°C (63-77°F) and should be protected from light. There are no added preservatives in the solution. For full prescribing information, refer to the package insert. This medication is manufactured by Teva Pharmaceuticals USA, Inc. in North Wales, PA, USA.*
FDA Label Image

Principal Display Panel (50 mL Vial Label)

Principal Display Panel (50 mL Vial Label)
This is a description of a 0 mL single-dose vial with a high potency formulation (HPF) manufactured by Teva Pharmaceuticals USA, Inc. The vial has a national drug code (NDC) of 0703-0018-01 and the lot number is ###8#AA with an expiration date listed as DHMMYYYY. The vial is intended for use in preparation and must be protected from light. The location of the company is listed as North Wales, PA 19454.*
FDA Label Image

Principal Display Panel (50 mL Vial Carton)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.